August 23, 2023

Rapport Therapeutics

Rapport Therapeutics Raises $150 Million in Series B Funding Round and Announces Key Board Appointments to Further Advance Precision Neuromedicine Platform

August 22, 2023

Fulcrum Therapeutics

FDA Lifts Clinical Hold on Fulcrum Therapeutics’ FTX-6058 for Sickle Cell Disease

August 11, 2023

Decibel Therapeutics

Decibel Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Update

August 10, 2023

Tango Therapeutics

Tango Therapeutics Announces $80 Million Private Placement Financing

August 09, 2023

Decibel Therapeutics

Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs

Load More

Sign up for weekly portfolio news.